Jim Simons Athersys, Inc Transaction History

Renaissance Technologies LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.18 - $0.86 $27,375 - $130,793	-152,085 Reduced 40.02%	227,900 $59,000
Q1 2022 May 13, 2022	BUY	$0.6 - $1.06 $227,991 - $402,784	379,985 New	379,985 $230,000
Q2 2021 Aug 13, 2021	SELL	$1.41 - $1.94 $374,783 - $515,659	-265,804 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$1.61 - $2.77 $427,944 - $736,277	265,804 New	265,804 $478,000
Q3 2020 Nov 13, 2020	SELL	$1.91 - $3.08 $35,908 - $57,904	-18,800 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$1.97 - $3.98 $1.84 Million - $3.71 Million	-932,223 Reduced 98.02%	18,800 $52,000
Q1 2020 May 14, 2020	BUY	$1.17 - $3.0 $11,442 - $29,340	9,780 Added 1.04%	951,023 $2.85 Million
Q4 2019 Feb 13, 2020	SELL	$1.16 - $1.42 $76,192 - $93,269	-65,683 Reduced 6.52%	941,243 $1.16 Million
Q3 2019 Nov 13, 2019	SELL	$1.21 - $1.65 $24,684 - $33,660	-20,400 Reduced 1.99%	1,006,926 $1.34 Million
Q2 2019 Aug 12, 2019	BUY	$1.39 - $2.03 $343,296 - $501,361	246,976 Added 31.65%	1,027,326 $1.73 Million
Q1 2019 May 14, 2019	BUY	$1.39 - $1.71 $798,837 - $982,742	574,703 Added 279.46%	780,350 $1.17 Million
Q4 2018 Feb 13, 2019	BUY	$1.41 - $2.16 $289,962 - $444,197	205,647 New	205,647 $296,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.